These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 17461727)

  • 21. Optical pretargeting of tumor with fluorescent MORF oligomers.
    He J; Rusckowski M; Wang Y; Dou S; Liu X; Zhang S; Liu G; Hnatowich DJ
    Mol Imaging Biol; 2007; 9(1):17-23. PubMed ID: 17171474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bispecific antibody pretargeting of tumor neovasculature for improved systemic radiotherapy of solid tumors.
    Moosmayer D; Berndorff D; Chang CH; Sharkey RM; Rother A; Borkowski S; Rossi EA; McBride WJ; Cardillo TM; Goldenberg DM; Dinkelborg LM
    Clin Cancer Res; 2006 Sep; 12(18):5587-95. PubMed ID: 17000696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 90Y labeled phosphorodiamidate morpholino oligomer for pretargeting radiotherapy.
    Liu G; Dou S; Liu Y; Wang Y; Rusckowski M; Hnatowich DJ
    Bioconjug Chem; 2011 Dec; 22(12):2539-45. PubMed ID: 21985267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Studies in a human colon cancer xenograft model.
    Sharkey RM; Karacay H; Griffiths GL; Behr TM; Blumenthal RD; Mattes MJ; Hansen HJ; Goldenberg DM
    Bioconjug Chem; 1997; 8(4):595-604. PubMed ID: 9258460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pretargeting with bispecific anti-renal cell carcinoma x anti-DTPA(In) antibody in 3 RCC models.
    van Schaijk FG; Oosterwijk E; Molkenboer-Kuenen JD; Soede AC; McBride BJ; Goldenberg DM; Oyen WJ; Corstens FH; Boerman OC
    J Nucl Med; 2005 Mar; 46(3):495-501. PubMed ID: 15750164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimizing bispecific antibody pretargeting for use in radioimmunotherapy.
    Sharkey RM; Karacay H; Richel H; McBride WJ; Rossi EA; Chang K; Yeldell D; Griffiths GL; Hansen HJ; Goldenberg DM
    Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3897S-913S. PubMed ID: 14506188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pretargeting vs. direct targeting of human betalox5 islet cells subcutaneously implanted in mice using an anti-human islet cell antibody.
    Liu G; Dou S; Akalin A; Rusckowski M; Streeter PR; Shultz LD; Greiner DL
    Nucl Med Biol; 2012 Jul; 39(5):645-51. PubMed ID: 22316614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving the delivery of radionuclides for imaging and therapy of cancer using pretargeting methods.
    Sharkey RM; Karacay H; Cardillo TM; Chang CH; McBride WJ; Rossi EA; Horak ID; Goldenberg DM
    Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7109s-7121s. PubMed ID: 16203810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation of (111)In-DTPA morpholino oligomer for low abdominal accumulation.
    Liu G; Dou S; Rusckowski M; Greiner D; Hnatowich D
    Appl Radiat Isot; 2010 Sep; 68(9):1709-14. PubMed ID: 20359901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting to tumor necrotic regions with biotinylated antibody and streptavidin modified liposomes.
    Pan H; Han L; Chen W; Yao M; Lu W
    J Control Release; 2008 Feb; 125(3):228-35. PubMed ID: 18022270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell studies of a three-component antisense MORF/tat/Herceptin nanoparticle designed for improved tumor delivery.
    Liu X; Wang Y; Nakamura K; Kubo A; Hnatowich DJ
    Cancer Gene Ther; 2008 Feb; 15(2):126-32. PubMed ID: 18084241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraperitoneal injection is not always a suitable alternative to intravenous injection for radiotherapy.
    Dou S; Smith M; Wang Y; Rusckowski M; Liu G
    Cancer Biother Radiopharm; 2013 May; 28(4):335-42. PubMed ID: 23469942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparing the intracellular fate of components within a noncovalent streptavidin nanoparticle with covalent conjugation.
    Liu Y; Cheng D; Liu X; Liu G; Dou S; Xiao N; Chen L; Rusckowski M; Hnatowich DJ
    Nucl Med Biol; 2012 Jan; 39(1):101-7. PubMed ID: 21958854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Replacing 99mTc with 111In improves MORF/cMORF pretargeting by reducing intestinal accumulation.
    Liu G; Cheng D; Dou S; Chen X; Liang M; Pretorius PH; Rusckowski M; Hnatowich DJ
    Mol Imaging Biol; 2009; 11(5):303-7. PubMed ID: 19326173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Affinity enhancement bivalent morpholino for pretargeting: initial evidence by surface plasmon resonance.
    He J; Liu G; Vanderheyden JL; Dou S; Mary R; Hnatowich DJ
    Bioconjug Chem; 2005; 16(2):338-45. PubMed ID: 15769087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Residualizing iodine markedly improved tumor targeting using bispecific antibody-based pretargeting.
    van Schaijk FG; Broekema M; Oosterwijk E; van Eerd JE; McBride BJ; Goldenberg DM; Corstens FH; Boerman OC
    J Nucl Med; 2005 Jun; 46(6):1016-22. PubMed ID: 15937314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pretargeted radioimmunotherapy in tumored mice using an in vivo 212Pb/212Bi generator.
    Su FM; Beaumier P; Axworthy D; Atcher R; Fritzberg A
    Nucl Med Biol; 2005 Oct; 32(7):741-7. PubMed ID: 16243650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trans-cyclooctene tag with improved properties for tumor pretargeting with the diels-alder reaction.
    Rossin R; van Duijnhoven SM; Läppchen T; van den Bosch SM; Robillard MS
    Mol Pharm; 2014 Sep; 11(9):3090-6. PubMed ID: 25077373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RNA aptamer-conjugated liposome as an efficient anticancer drug delivery vehicle targeting cancer cells in vivo.
    Baek SE; Lee KH; Park YS; Oh DK; Oh S; Kim KS; Kim DE
    J Control Release; 2014 Dec; 196():234-42. PubMed ID: 25450401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new Tri-Fab bispecific antibody for pretargeting Trop-2-expressing epithelial cancers.
    Sharkey RM; van Rij CM; Karacay H; Rossi EA; Frielink C; Regino C; Cardillo TM; McBride WJ; Chang CH; Boerman OC; Goldenberg DM
    J Nucl Med; 2012 Oct; 53(10):1625-32. PubMed ID: 22952342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.